Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Synthetic biofilter wins through to the top ‘Sweet Sixteen’ in Boston

07.11.2012
Bielefeld students on a par with teams from international elite universities

Months of painstaking work in the laboratory at Bielefeld University‘s Center for Biotechnology (CeBiTec) have paid off: the 15 students participating in this year’s ‘international Genetically Engineered Machine competition’ (iGEM) at the Massachusetts Institute of Technology (MIT) have good reason to celebrate.

The goal of their project was to develop a biological filter that removes estrogen from drinking water. It was a success: they managed to produce enzymes that break down the hormone. On Monday 5 November, the competition finals came to a close in Boston.

From 190 teams throughout the world, Bielefeld’s students made it through to the ‘Sweet Sixteen’, the selection of the 16 best teams in the company of teams from such prestigious universities as Stanford University (USA), the Canadian University of Calgary, and Jiaotong University in Shanghai, China.

More than 70 teams from throughout the world got through to the finals of the top student competition in synthetic biology. The Bielefeld team was one of five German teams at the start. Bielefeld University has now participated in the iGEM competition for the third year running and already succeeded in qualifying for Boston in 2010 and 2011.

This year’s team, like its predecessors, made it into the ‘Sweet Sixteen’. ‘We stand in direct comparison with universities like Stanford and Cornell. At first, that seemed very intimidating, but we soon noticed they were having to fight exactly the same problems as we were. And with our know-how, we can match the pace here’, says Moritz Müller, a master student of molecular biotechnology.

Enzymes from fungi growing on trees filter out medicine residues from sewage and drinking water

Conventional methods of filtering waste water in sewage treatment plants are unable to completely remove medicine residues such as the estrogens in birth control pills. These residues then find their way into rivers and lakes and also accumulate in our drinking water. For fish and other aquatic life, estrogens can lead to reproductive and developmental disorders and even to the formation of female characteristics in males. The potential long-term consequences for human beings – declining sperm counts, infertility, various cancers, and osteoporosis – are still largely unknown.

The Bielefeld iGEM team has developed a biological filter in which specific enzymes (so-called laccases) break down these medicine residues. One known source of particularly efficient laccases is the turkey tail, a type of fungus that grows on trees. Using methods from synthetic biology, the students succeeded in synthesizing this enzyme and applying it to filter material.

‘We didn’t want to invent something totally crazy with our project – just because it’s technically feasible. We wanted to do something that could actually be put to use in the near future, perhaps in 20 years, and be a real benefit’, explains Robert Braun, a master student of molecular biotechnology.

‘The biofilter is such a project. And we have shown that our idea works. In principle, a company could now come along and develop our filter further. We ourselves have got to get back to our studies – most of us have rather neglected them for the last 6 months. However, the experiences we have gathered more than compensate for that’.

International competition

The iGEM competition has been held every year since 2003 by the Massachusetts Institute of Technology (MIT) in Boston. Starting as an MIT study course, the number of competitors has grown rapidly from five teams in 2004 to 190 in the present year. All teams face the same task: taking their project from the idea across the laboratory work to gaining funding and communicating the findings. On the student level, the iGEM can be seen as the world championship in synthetic biology that shows the future potential of this still young field of research. The Bielefeld iGEM team is being funded by Bielefeld University‘s Center for Biotechnology (CeBiTec) and the BIO.NRW Cluster Biotechnology North Rhine-Westphalia.

Contact:
Robert Braun, Bielefeld University
iGEM-Team Bielefeld-Germany
Telephone: 0162 3167424
Email: rbraun@igem-bielefeld.de

Ingo Lohuis | idw
Further information:
http://www.igem-bielefeld.de
http://2012.igem.org/Team:Bielefeld-Germany

More articles from Awards Funding:

nachricht Siemens Velaro train wins "Red Dot" award
01.07.2015 | Siemens AG

nachricht New SNSF funding programme for independent clinical research
26.06.2015 | Schweizerischer Nationalfonds SNF

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Viaducts with wind turbines, the new renewable energy source

Wind turbines could be installed under some of the biggest bridges on the road network to produce electricity. So it is confirmed by calculations carried out by a European researchers team, that have taken a viaduct in the Canary Islands as a reference. This concept could be applied in heavily built-up territories or natural areas with new constructions limitations.

The Juncal Viaduct, in Gran Canaria, has served as a reference for Spanish and British researchers to verify that the wind blowing between the pillars on this...

Im Focus: X-rays and electrons join forces to map catalytic reactions in real-time

New technique combines electron microscopy and synchrotron X-rays to track chemical reactions under real operating conditions

A new technique pioneered at the U.S. Department of Energy's Brookhaven National Laboratory reveals atomic-scale changes during catalytic reactions in real...

Im Focus: Iron: A biological element?

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and a half billion years ago.

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and...

Im Focus: Thousands of Droplets for Diagnostics

Researchers develop new method enabling DNA molecules to be counted in just 30 minutes

A team of scientists including PhD student Friedrich Schuler from the Laboratory of MEMS Applications at the Department of Microsystems Engineering (IMTEK) of...

Im Focus: Bionic eye clinical trial results show long-term safety, efficacy vision-restoring implant

Patients using Argus II experienced significant improvement in visual function and quality of life

The three-year clinical trial results of the retinal implant popularly known as the "bionic eye," have proven the long-term efficacy, safety and reliability of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

World Conference on Regenerative Medicine in Leipzig: Last chance to submit abstracts until 2 July

25.06.2015 | Event News

World Conference on Regenerative Medicine: Abstract Submission has been extended to 24 June

16.06.2015 | Event News

MUSE hosting Europe’s largest science communication conference

11.06.2015 | Event News

 
Latest News

Siemens receives order for offshore wind power plant in Great Britain

03.07.2015 | Press release

'Déjà vu all over again:' Research shows 'mulch fungus' causes turfgrass disease

03.07.2015 | Agricultural and Forestry Science

Discovery points to a new path toward a universal flu vaccine

03.07.2015 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>